The effect of aging on fMRI: Correction for the effects of vascular reactivity

Important paper from Tsvetanov, Cam-CAN et al. on vascular effects in aging in a sample of 335 subjects.

The scaling analysis revealed that much of the effects of age on task-based activation studies with fMRI do not survive correction for changes in vascular reactivity, and are likely to have been overestimated in previous fMRI studies of ageing.

The $PATH to Enlightenment

Great introduction to the Unix/OS X $PATH variable (and the command line) from A List Apart.

The command line is inherently spooky to many people—it’s the arcane technology wielded by “hackers” and “computer wizards” in popular culture. In reality, though, it isn’t that cool. It’s a set of ridiculously simple tools created by Bell (now AT&T) employees to accomplish mostly simple tasks in the 1970s. It’s about as “space-age” as your microwave oven.

It’s also extremely useful—like going from building a house by hand to using power tools. And through a few concepts and metaphors, we can shine a light on the darkest corners of this command line.

I wish I'd known then what I know now

Lots of great advice in the form of reflections—these ring true to me.

7 Be willing to take on tasks you’re not sure you’re completely qualified to do.

If you never do this, not only will you not discover what your strengths are but you also won’t ever acquire these additional skills. Should I be apologetic that the first Research Council committee I chaired I didn’t know what a lot of the acronyms meant when I first sat down to read the applications? No, I don’t think so.

Neuroscience achieving insight from code-breaking

The Enigma machine and de Bruijn sequences inform neuroscience analyses, including quotes from Josh Gold and Geoff Aguirre.

The Penn scientists have taken their cues from a 73-year-old algorithm that British code-breaker Alan Turing used to read secret German messages during World War II, and a mathematical sequence more famously used to break into digital keypad locks on cars.

NIH proposes "emeritus award" for senior PIs

Commentary from Datahound.

(1) This problem already has a solution. An investigator can (with approval from the relevant IC) name a new Principal Investigator for a grant. Assuming the PI is qualified and NIH approves, this is an effective transition strategy that has been used many times.

(2) For most research programs, is "succession planning" something that NIH staff are worried about? Given that many investigators train numerous younger scientists over the course of their careers and that the system is currently flooded with accomplished younger scientists, the solution to this problem without any mechanism seems to be at hand.

(3) Even proposing such a mechanism seems quite inappropriate and tone deaf at this juncture when so many younger scientists are struggling to establish and maintain their careers.

If money were flowing freely, there may be some positive things coming out of this iniative. But in the "current funding climate" I don't see how this is helpful.

What does a Bayes factor look like?

Helpful visualization from Felix Schönbrodt.

To summarize: Whether a strong evidence “hits you between the eyes” depends on many things – the kind of test, the kind of visualization, the sample size. Sometimes a BF of 2.5 seems obvious, and sometimes it is hard to spot a BF>100 by eyeballing only. Overall, I’m glad that we have a numeric measure of strength of evidence and do not have to rely on eyeballing only.

eNeuro encourages submission of negative results

Negative Results: Research papers from authors who tried to test important hypotheses but did not get the outcome they expected. Failed preclinical tests are particularly welcome. These manuscripts must include testing the hypothesis by multiple experimental approaches, rigorously reproducing the experimental models of others that you claim to refute, and meticulous use of both positive and negative controls.

Failure to Replicate: Research papers from authors who could not reproduce someone else’s work of significant importance despite using the same methodology (explaining why the reproduction failed is not mandatory).

Refreshing.

(I'm not a big fan of media-specific journal titles like eLife or eNeuro—it's not like we have printJournal of Neuroscience—but I do like some of the changes they are instituting.)

UPDATE: Greg Hickok confirms that Psychonomic Bulletin and Review also encourages negative results (although this isn't spelled out on their website). Is there a central list of "journals that are happy to publish your negative results"?